{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:11:47Z","timestamp":1784740307968,"version":"3.55.0"},"reference-count":79,"publisher":"BMJ","issue":"10","funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000659","name":"Research Trainees Coordinating Centre","doi-asserted-by":"publisher","award":["PDF-2014-07-008"],"award-info":[{"award-number":["PDF-2014-07-008"]}],"id":[{"id":"10.13039\/501100000659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1136\/thoraxjnl-2015-208262","type":"journal-article","created":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T02:44:03Z","timestamp":1465872243000},"page":"940-949","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis"],"prefix":"10.1136","volume":"71","author":[{"given":"H R","family":"Stagg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R J","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-A","family":"Hatherell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Obach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1148-6240","authenticated-orcid":false,"given":"H","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kranzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Nikolayevskyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"Lipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Abubakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,6,13]]},"reference":[{"key":"key-10.1136\/thoraxjnl-2015-208262-1","unstructured":"World Health Organization. Global tuberculosis report 2015. 2015. http:\/\/www.who.int\/tb\/publications\/global_report\/en\/ (accessed 2 Nov 2015)."},{"key":"key-10.1136\/thoraxjnl-2015-208262-2","doi-asserted-by":"crossref","first-page":"e22927","DOI":"10.1371\/journal.pone.0022927","article-title":"Quantifying the burden and trends of isoniazid resistant tuberculosis, 1994\u20132009","volume":"6","author":"Jenkins","year":"2011","journal-title":"Plos One"},{"key":"key-10.1136\/thoraxjnl-2015-208262-3","volume-title":"Treatment of tuberculosis: guidelines","author":"World Health Organization","year":"2009","edition":"4"},{"key":"key-10.1136\/thoraxjnl-2015-208262-4","volume-title":"Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis","author":"World Health Organization","year":"2014"},{"key":"key-10.1136\/thoraxjnl-2015-208262-5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2015-208262-6","unstructured":"National Institute for Health and Care Excellence. Tuberculosis. 2016. http:\/\/www.nice.org.uk\/guidance\/ng33\/resources\/tuberculosis-prevention-diagnosis-management-and-service-organisation-1837390683589 (accessed 14 Jan 2016)."},{"key":"key-10.1136\/thoraxjnl-2015-208262-7","doi-asserted-by":"crossref","first-page":"e1000146","DOI":"10.1371\/journal.pmed.1000146","article-title":"Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis","volume":"6","author":"Menzies","year":"2009","journal-title":"PLoS Med"},{"key":"key-10.1136\/thoraxjnl-2015-208262-8","doi-asserted-by":"crossref","first-page":"e1000150","DOI":"10.1371\/journal.pmed.1000150","article-title":"Standardized treatment of active tuberculosis in patients with previous treatment and\/or with mono-resistance to isoniazid: a systematic review and meta-analysis","volume":"6","author":"Menzies","year":"2009","journal-title":"PLoS Med"},{"key":"key-10.1136\/thoraxjnl-2015-208262-9","first-page":"423","article-title":"Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis","volume":"133","author":"Mitchison","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-10","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/sim.1566","article-title":"A chain of evidence with mixed comparisons: models for multi-parameter synthesis and consistency of evidence","volume":"22","author":"Ades","year":"2003","journal-title":"Stat Med"},{"key":"key-10.1136\/thoraxjnl-2015-208262-11","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/sim.1201","article-title":"Network meta-analysis for indirect treatment comparisons","volume":"21","author":"Lumley","year":"2002","journal-title":"Stat Med"},{"key":"key-10.1136\/thoraxjnl-2015-208262-12","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Br Med J"},{"key":"key-10.1136\/thoraxjnl-2015-208262-13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1536867X0800800102","article-title":"metan: fixed- and random-effects meta-analysis","volume":"8","author":"Harris","year":"2008","journal-title":"Stata J"},{"key":"key-10.1136\/thoraxjnl-2015-208262-14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.7326\/M14-1019","article-title":"Treatment of latent tuberculosis infection: a network meta-analysis","volume":"161","author":"Stagg","year":"2014","journal-title":"Ann Intern Med"},{"key":"key-10.1136\/thoraxjnl-2015-208262-15","unstructured":"Dias S , Welton NJ , Sutton AJ , et al. NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials. 2014. http:\/\/www.nicedsu.org.uk\/TSD2%20General%20meta%20analysis%20corrected%2015April2014.pdf (accessed Apr 2014)."},{"key":"key-10.1136\/thoraxjnl-2015-208262-16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1749-6632.1966.tb45528.x","article-title":"Clinical evaluation of ethambutol in pulmonary tuberculosis","volume":"135","author":"Donomae","year":"1966","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.1136\/thoraxjnl-2015-208262-17","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1128\/AAC.00874-09","article-title":"Prospective randomized trial of six-month versus nine-month therapy for intestinal tuberculosis","volume":"53","author":"Park","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.1136\/thoraxjnl-2015-208262-18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-3156.2004.01229.x","article-title":"Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis\u2014a unique approach","volume":"9","author":"Santha","year":"2004","journal-title":"Trop Med Int Health"},{"key":"key-10.1136\/thoraxjnl-2015-208262-19","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1164\/ajrccm.157.6.9707037","article-title":"Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis\u2014Initial report","volume":"157","author":"Tam","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2015-208262-20","first-page":"509","article-title":"A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis","volume":"1","author":"Mathew","year":"1997","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-21","first-page":"423","article-title":"Controlled clinical trial of rifapentine given once weekly or fortnightly in 6-month regimes for the treatment of bacillary tuberculosis: Results at 3-year follow-up","volume":"22","author":"National Cooperative Group on Clinical Study of Rifapentine","year":"1997","journal-title":"Zhongguo Kang Sheng Su Za Zhi"},{"key":"key-10.1136\/thoraxjnl-2015-208262-22","first-page":"960","article-title":"A controlled trial of a 4-weekly supplement of rifampicin, pyrazinamide and streptomycin in the continuation phase of a 7-month daily chemotherapy regimen for pulmonary tuberculosis","volume":"86","author":"Tanzania\/British Medical Research Council","year":"1996","journal-title":"S Afr Med J"},{"key":"key-10.1136\/thoraxjnl-2015-208262-23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1164\/ajrccm\/143.4_Pt_1.707","article-title":"Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis","volume":"143","author":"Singapore Tuberculosis Service, British Medical Research Council","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-24","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1164\/ajrccm\/140.4.990","article-title":"Controlled clinical trial of levamisole in short-course chemotherapy for pulmonary tuberculosis. A Kenyan\/Zambian\/British Medical Research Council Collaborative Study","volume":"140","author":"Kenyan Zambian British Medical Research Council","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-25","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1164\/ajrccm\/139.4.871","article-title":"A controlled trial of 3-month, 4-month and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years","volume":"139","author":"Hong Kong Chest Service, Tuberculosis Research Centre Madras, British Medical Research Council","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0041-3879(88)90047-5","article-title":"Comparison of a daily and three intermittent retreatment regimens for pulmonary tuberculosis administered under programme conditions","volume":"69","author":"Hong","year":"1988","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0041-3879(88)90035-9","article-title":"Controlled clinical-trial of a regimen of two durations for the treatment of isoniazid resistant pulmonary tuberculosis","volume":"69","author":"Babu Swai","year":"1988","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-28","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/ajrccm\/137.5.1147","article-title":"Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis","volume":"137","author":"Singapore Tuberculosis Service-British Medical Research Council","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-29","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1164\/ajrccm\/136.6.1339","article-title":"Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis","volume":"136","author":"Hong Kong Chest Service\/British Medical Research Council","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-30","first-page":"27","article-title":"A controlled clinical-trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India","volume":"134","author":"Prabhakar","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0041-3879(86)90027-9","article-title":"Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African\/British Medical Research Council Fifth Collaborative Study","volume":"67","author":"East and Central African\/British Medical Research Council","year":"1986","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-32","first-page":"779","article-title":"Long-term follow-up of a clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis","volume":"133","author":"Singapore Tuberculosis Service British Medical Research Council","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-33","first-page":"727","article-title":"Controlled clinical trial of two 6-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Tanzania\/British Medical Research Council Study","volume":"131","author":"Tanzania-British Medical Research Council Study","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-34","first-page":"23","article-title":"A controlled trial of 2\u2013month, 3-month, and 12 month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 60 months","volume":"130","author":"Tuberculosis Research Centre Madras, British Medical Research Council","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0041-3879(83)90032-6","article-title":"Study of chemotherapy regimens of 5 and 7 months\u2019 duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India","volume":"64","author":"Tuberculosis Research Centre India","year":"1983","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-36","first-page":"165","article-title":"Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study","volume":"123","author":"East African British Medical Research Council","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0041-3879(81)90031-3","article-title":"Ethambutol plus isoniazid for the treatment of pulmonary tuberculosis\u2014a controlled trial of four regimens","volume":"62","author":"The Tuberculosis Research Centre","year":"1981","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0041-3879(80)90012-4","article-title":"Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis. Second report. Third East African\/British Medical Research Council Study","volume":"61","author":"East African\/British Medical Research Council","year":"1980","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-39","first-page":"879","article-title":"Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment","volume":"122","author":"Zierski","year":"1980","journal-title":"Am Rev Respir Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0041-3879(79)90001-1","article-title":"Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis: the results up to 24 months","volume":"60","author":"Hong Kong Chest Service, British Medical Research Council","year":"1979","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-41","first-page":"807","article-title":"Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore. Results up to 30 months","volume":"116","author":"Girling","year":"1977","journal-title":"Am Rev Respir Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-42","first-page":"727","article-title":"Controlled trial of 6-month and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong-Kong. The results up to 30 months","volume":"115","author":"Hong Kong Chest Service, British Medical Research Council","year":"1977","journal-title":"Am Rev Respir Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0041-3879(76)90047-7","article-title":"A comparative study of daily followed by twice- or once-weekly regimens of ethambutol and rifampicin in the retreatment of patients with pulmonary tuberculosis: second report","volume":"57","author":"National Research Institute for Tuberculosis Poland","year":"1976","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-44","first-page":"471","article-title":"Controlled clinical trial of four 6-month regimens of chemotherapy for pulmonary tuberculosis. Second report","volume":"114","author":"Second East African British Medical Research Council Study","year":"1976","journal-title":"Am Rev Respir Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-45","first-page":"237","article-title":"Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report","volume":"2","author":"East African British Medical Research Councils","year":"1974","journal-title":"Lancet"},{"key":"key-10.1136\/thoraxjnl-2015-208262-46","first-page":"447","article-title":"Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) I. Clinical course","volume":"49","author":"Horsfall","year":"1974","journal-title":"Bull Int Union Tuberc"},{"key":"key-10.1136\/thoraxjnl-2015-208262-47","first-page":"7","article-title":"The effect of adding thiacetazone or p amino salicylic-acid to the regimen of twice weekly streptomycin and isoniazid in patients with pulmonary tuberculosis an international controlled trial","volume":"49","author":"Bignall","year":"1974","journal-title":"Bull Int Union Tuberc"},{"key":"key-10.1136\/thoraxjnl-2015-208262-48","first-page":"125","article-title":"Comparative study (in a controlled therapeutic trial) of 3 intermittent regimens, after an initial period of daily administration, in the repeated treatment of pulmonary tuberculosis (results)","volume":"48","author":"Fraga","year":"1973","journal-title":"Bull Int Union Tuberc"},{"key":"key-10.1136\/thoraxjnl-2015-208262-49","first-page":"559","article-title":"Intermittent treatment of \u201cintractable chronic tuberculosis\u201d by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria","volume":"34","author":"Larbaoui","year":"1970","journal-title":"Rev Tuberc Pneumol (Paris)"},{"key":"key-10.1136\/thoraxjnl-2015-208262-50","first-page":"115","article-title":"Cooperative controlled trial of thiocarlide (DATC), PAS and bedrest alone in short-term single-drug treatment in retreated cavitary pulmonary tuberculosis","volume":"139","author":"Wissenschaftliche Arbeitsgemeinschaft fur die Therapie von Lungenkrankheiten","year":"1969","journal-title":"Beitr Klin Erforsch Tuberk Lungenkr"},{"key":"key-10.1136\/thoraxjnl-2015-208262-51","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0041-3879(91)90034-P","article-title":"Short-course chemotherapy for pulmonary tuberculosis under routine programme conditions: a comparison of regimens of 28 and 36 weeks duration in Algeria","volume":"72","author":"Algerian Working Group\/British Medical Research Council Cooperative Study","year":"1991","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-52","first-page":"73","article-title":"Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment","volume":"3","author":"Berkani","year":"1986","journal-title":"Rev Mal Respir"},{"key":"key-10.1136\/thoraxjnl-2015-208262-53","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0962-8479(95)90006-3","article-title":"Clinical trial of a combination of three drugs in fixed proportions in the treatment of tuberculosis. Groupe de Travail sur la Chimiotherapie de la Tuberculose","volume":"76","author":"Chaulet","year":"1995","journal-title":"Tuber Lung Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-54","first-page":"9","article-title":"[Efficiency of a new standard chemotherapy regimen in the treatment of patients with recurrent pulmonary tuberculosis.]","volume":"8","author":"Chukanov","year":"2006","journal-title":"Probl Tuberk Bolezn Legk"},{"key":"key-10.1136\/thoraxjnl-2015-208262-55","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1055\/s-0028-1108737","article-title":"Combined rifampicin-ethambutol therapy of resistant pulmonary tuberculosis. Effectiveness of various rifampicin doses in combination with ethambutol","volume":"95","author":"Hetrick","year":"1970","journal-title":"Dtsch Med Wochenschr"},{"key":"key-10.1136\/thoraxjnl-2015-208262-56","first-page":"209","article-title":"Controlled study comparing 3 daily chemotherapy regimens for six months in pulmonary tuberculosis in routine practice in Algiers. Results at 30 months","volume":"2","author":"Mazouni","year":"1985","journal-title":"Rev Mal Respir"},{"key":"key-10.1136\/thoraxjnl-2015-208262-57","doi-asserted-by":"crossref","first-page":"741","DOI":"10.5588\/ijtld.10.0392","article-title":"Results at 30 months of a randomised trial of two 8-month regimens for the treatment of tuberculosis","volume":"15","author":"Nunn","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-58","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1164\/rccm.200903-0439OC","article-title":"Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial","volume":"181","author":"Swaminathan","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2015-208262-59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0041-3879(73)90013-5","article-title":"A controlled comparison of two fully supervised once-weekly regimens in the treatment of newly diagnosed pulmonary tuberculosis","volume":"54","author":"Tuberculosis Chemotherapy Centre Madras","year":"1973","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-60","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0041-3879(70)90067-X","article-title":"Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa--fifth investigation. A co-operative study in East African hospitals, clinics and laboratories with the collaboration of the East African and British Medical Research Councils","volume":"51","author":"East African\/British Medical Research Council","year":"1970","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0041-3879(77)90013-7","article-title":"A study of two twice-weekly and a once-weekly continuation regimen of tuberculosis chemotherapy, including a comparison of two durations of treatment. II. Second report: the results at 36 months","volume":"58","author":"WHO Collaborating Centre for Tuberculosis Chemotherapy P","year":"1977","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-62","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0041-3879(74)90034-8","article-title":"A controlled clinical trial of the role of thiacetazone-containing regimens in the treatment of pulmonary tuberculosis in Singapore: second report","volume":"55","author":"Singapore Tuberculosis Services\/Brompton Hospital\/British Medical Research Council","year":"1974","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-63","first-page":"247","article-title":"A concurrent comparison of intermittent (twice-weekly) isoniazid plus streptomycin and daily isoniazid plus PAS in the domiciliary treatment of pulmonary tuberculosis","volume":"31","author":"Tuberculosis Chemotherapy Centre","year":"1964","journal-title":"Bull World Health Organ"},{"key":"key-10.1136\/thoraxjnl-2015-208262-64","first-page":"1960","article-title":"Comparative trial of isoniazid in combination with thiacetazone or a substituted diphenylthiourea (su 1906) or pas in the treatment of acute pulmonary tuberculosis in east Africans. A cooperative investigation in East African hospitals and laboratories with the collaboration of the British Medical Research Council","volume":"41","author":"East African\/British Medical Research Council","year":"1960","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-65","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000386812","article-title":"Controlled clinical trials with Isoxyl","volume":"16","author":"B\u00f6sz\u00f6rm\u00e9nyi","year":"1970","journal-title":"Antibiot Chemother"},{"issue":"1","key":"key-10.1136\/thoraxjnl-2015-208262-66","first-page":"700","volume":"143","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"key-10.1136\/thoraxjnl-2015-208262-67","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0041-3879(64)80045-3","article-title":"A controlled trial of ethionamide with isoniazid in the treatment of pulmonary tuberculosis in Hong Kong","volume":"45","author":"Sundberg","year":"1964","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-68","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0041-3879(64)80072-6","article-title":"A controlled comparison of streptomycin plus pyrazinamide and streptomycin plus pas in the retreatment of patients excreting isoniazid-resistant organisms","volume":"45","author":"Velu","year":"1964","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-69","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4046\/trd.1981.28.3.95","article-title":"Comparison of retreatment regimens for pulmonary tuberculosis under programme condition","volume":"28","author":"Young","year":"1981","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"key-10.1136\/thoraxjnl-2015-208262-70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0041-3879(63)80114-2","article-title":"Ethionamide, Pyrazinamide and Cycloserine in the Treatment of Drug-Resistant Pulmonary Tuberculosis","volume":"44","author":"Research Committee of the British Tuberculosis Association","year":"1963","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-71","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0041-3879(63)80082-3","article-title":"Influence of pretreatment bacterial resistance to isoniazid, thiacetazone or pas on the response to chemotherapy of African patients with pulmonary tuberculosis","volume":"44","author":"Research Committee of the British Tuberculosis Association","year":"1963","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-72","first-page":"551","article-title":"Ambulatory intermittent rifampicin and ethambutol in the retreatment of pulmonary tuberculosis","volume":"57","author":"Sriyabhaya","year":"1974","journal-title":"J Med Assoc Thai"},{"key":"key-10.1136\/thoraxjnl-2015-208262-73","first-page":"807","article-title":"Response of patients infected with isoniazid-resistant tubercle bacilli to treatment with isoniazid plus PAS or isoniazid alone","volume":"25","author":"Devadatta","year":"1961","journal-title":"Bull World Health Organ"},{"key":"key-10.1136\/thoraxjnl-2015-208262-74","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0041-3879(68)80008-X","article-title":"A comparison of two regimens of streptomycin plus PAS in the retreatment of pulmonary tuberculosis","volume":"49","author":"East African\/British Medical Research Council","year":"1968","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-75","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1128\/AAC.00077-13","article-title":"Epidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomes","volume":"57","author":"Huyen","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.1136\/thoraxjnl-2015-208262-76","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0041-3879(75)90054-9","article-title":"Reappraisal of the activity of morphazinamide against M. tuberculosis","volume":"56","author":"Carrada Bravo","year":"1975","journal-title":"Tubercle"},{"key":"key-10.1136\/thoraxjnl-2015-208262-77","first-page":"140","article-title":"Toxicity of morphazinamide compared with pyrazinamide","volume":"6","author":"Zitkov\u00e1","year":"1983","journal-title":"Czech Med"},{"key":"key-10.1136\/thoraxjnl-2015-208262-78","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1314210","article-title":"High-dose rifapentine with moxifloxacin for pulmonary tuberculosis","volume":"371","author":"Jindani","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.1136\/thoraxjnl-2015-208262-79","doi-asserted-by":"crossref","first-page":"866","DOI":"10.5588\/ijtld.16.0034","article-title":"Treatment regimens for rifampicin resistant tuberculosis: highlighting a research gap","volume":"20","author":"Stagg","year":"2016","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2015-208262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T17:42:11Z","timestamp":1656697331000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2015-208262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,13]]},"references-count":79,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,9,13]]},"published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1136\/thoraxjnl-2015-208262"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2015-208262","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,13]]}}}